复发性高级别胶质瘤的治疗选择。
Treatment options for recurrent high-grade gliomas.
作者信息
Birk Harjus S, Han Seunggu J, Butowski Nicholas A
机构信息
Department of Neurological Surgery, University of California, San Francisco, CA, USA.
出版信息
CNS Oncol. 2017 Jan;6(1):61-70. doi: 10.2217/cns-2016-0013. Epub 2016 Dec 21.
Abstract
High-grade gliomas are aggressive brain tumors encompassing Grade III and IV classifications. Of these, glioblastoma (GB) is the most malignant with a high rate of recurrence after initial resection. Although standard treatment does exist for newly diagnosed GBs, therapeutic strategies for recurrent GB are less solidified. However, mounting evidence describes the role of re-resection, bevacizumab, chemotherapy, targeted molecular therapies, immunotherapeutic approaches and radiotherapy in recurrent GB management. This review article provides analysis of the aforementioned therapies, through assessing their effect on overall survival. Because GB tumor heterogeneity is prevalent there is a constant need to investigate therapies targeting recurrence. Studies evaluating both therapeutic targets and strategies for high-grade gliomas are and will remain invaluable.
摘要
高级别胶质瘤是侵袭性脑肿瘤，包括III级和IV级分类。其中，胶质母细胞瘤（GB）恶性程度最高，初次切除后复发率很高。虽然新诊断的GB有标准治疗方法，但复发性GB的治疗策略尚未完全确立。然而，越来越多的证据表明再次切除、贝伐单抗、化疗、靶向分子疗法、免疫治疗方法和放疗在复发性GB治疗中的作用。这篇综述文章通过评估上述疗法对总生存期的影响，对其进行了分析。由于GB肿瘤异质性普遍存在，因此一直需要研究针对复发的疗法。评估高级别胶质瘤治疗靶点和策略的研究过去是、将来也仍将是非常有价值的。
相似文献
1
Treatment options for recurrent high-grade gliomas.复发性高级别胶质瘤的治疗选择。
CNS Oncol. 2017 Jan;6(1):61-70. doi: 10.2217/cns-2016-0013. Epub 2016 Dec 21.
2
Treatment of recurrent high-grade gliomas.复发性高级别胶质瘤的治疗。
Curr Opin Neurol. 2009 Dec;22(6):657-64. doi: 10.1097/WCO.0b013e32833229e3.
3
Reirradiation with concurrent bevacizumab for recurrent high-grade gliomas in adult patients.贝伐单抗同步再程放疗用于成人复发性高级别胶质瘤患者
Cancer Radiother. 2018 Feb;22(1):9-16. doi: 10.1016/j.canrad.2017.06.013. Epub 2017 Dec 6.
4
Effectiveness of Stereotactic Radiotherapy and Bevacizumab for Recurrent High-Grade Gliomas: A Potential Therapy for Isocitrate Dehydrogenase Wild-Type Recurrent High-Grade Gliomas.立体定向放射治疗与贝伐单抗治疗复发性高级别胶质瘤的疗效：异柠檬酸脱氢酶野生型复发性高级别胶质瘤的潜在治疗方法
World Neurosurg. 2018 Jun;114:e1138-e1146. doi: 10.1016/j.wneu.2018.03.161. Epub 2018 Mar 31.
5
Recurrent malignant gliomas.复发性恶性胶质瘤
Semin Radiat Oncol. 2014 Oct;24(4):289-98. doi: 10.1016/j.semradonc.2014.06.006.
6
Re-resection for recurrent high-grade glioma in the setting of re-irradiation: more is not always better.在再次放疗背景下对复发性高级别胶质瘤进行再次切除：并非切除范围越大越好。
J Neurooncol. 2015 Sep;124(2):215-21. doi: 10.1007/s11060-015-1825-y. Epub 2015 May 30.
7
Current status of local therapy in malignant gliomas--a clinical review of three selected approaches.恶性脑胶质瘤的局部治疗现状——三种选定方法的临床评价。
Pharmacol Ther. 2013 Sep;139(3):341-58. doi: 10.1016/j.pharmthera.2013.05.003. Epub 2013 May 18.
8
Recurrent malignant glioma in adults.成人复发性恶性胶质瘤
Curr Treat Options Oncol. 2002 Dec;3(6):509-24. doi: 10.1007/s11864-002-0070-8.
9
Patterns of failure after concurrent bevacizumab and hypofractionated stereotactic radiation therapy for recurrent high-grade glioma.贝伐珠单抗联合低分割立体定向放疗治疗复发性高级别胶质瘤后的失败模式。
Int J Radiat Oncol Biol Phys. 2013 Mar 1;85(3):636-42. doi: 10.1016/j.ijrobp.2012.05.031. Epub 2012 Jul 3.
10
Approved Treatments for Patients with Recurrent High-grade Gliomas.复发性高级别胶质瘤患者的获批治疗方法。
Semin Oncol Nurs. 2018 Dec;34(5):486-493. doi: 10.1016/j.soncn.2018.10.005. Epub 2018 Nov 2.
引用本文的文献
1
Beyond the blood-brain barrier: feasibility and technical validation of dual-compartment circulating tumor cells detection in high-grade glioma patients.突破血脑屏障：高级别胶质瘤患者双室循环肿瘤细胞检测的可行性及技术验证
Neurosurg Rev. 2025 Apr 11;48(1):359. doi: 10.1007/s10143-025-03511-3.
2
Pattern of recurrence after fractionated stereotactic reirradiation in adult glioblastoma.成人胶质母细胞瘤分次立体定向再照射后的复发模式
Radiat Oncol. 2025 Feb 28;20(1):28. doi: 10.1186/s13014-025-02611-0.
3
Identification of genetic modifiers enhancing B7-H3-targeting CAR T cell therapy against glioblastoma through large-scale CRISPRi screening.通过大规模 CRISPRi 筛选鉴定增强 B7-H3 靶向 CAR T 细胞治疗胶质母细胞瘤的遗传修饰物。
J Exp Clin Cancer Res. 2024 Apr 1;43(1):95. doi: 10.1186/s13046-024-03027-6.
4
Operative planning for a functional precision medicine assay of recurrent high-grade glioma: illustrative case.复发性高级别胶质瘤功能精准医学检测的手术规划：病例说明
J Neurosurg Case Lessons. 2024 Feb 12;7(7). doi: 10.3171/CASE23679.
5
Use of Bevacizumab in recurrent glioblastoma: a scoping review and evidence map.贝伐珠单抗在复发性脑胶质瘤中的应用：范围综述和证据图谱。
BMC Cancer. 2023 Jun 14;23(1):544. doi: 10.1186/s12885-023-11043-6.
6
Outcome of Second Line Treatment of Recurrent High- Grade Glioma by re-Irradiation or Bevacizumab-based Chemotherapy: A Cross Sectional Study.复发性高级别胶质瘤二线治疗（再放疗或贝伐珠单抗为基础的化疗）的结果：一项横断面研究。
Asian Pac J Cancer Prev. 2023 May 1;24(5):1507-1511. doi: 10.31557/APJCP.2023.24.5.1507.
7
Intravoxel incoherent motion for differentiating residual/recurrent tumor from post-treatment change in patients with high-grade glioma.体素内不相干运动在鉴别高级别脑胶质瘤患者肿瘤残留/复发与治疗后改变中的应用。
Neuroradiol J. 2023 Dec;36(6):657-664. doi: 10.1177/19714009231173108. Epub 2023 Apr 27.
8
Immunohistochemical assessment and clinical, histopathologic, and molecular correlates of membranous somatostatin type-2A receptor expression in high-risk pediatric central nervous system tumors.高危儿童中枢神经系统肿瘤中膜性生长抑素2A型受体表达的免疫组织化学评估及临床、组织病理学和分子相关性
Front Oncol. 2022 Nov 17;12:996489. doi: 10.3389/fonc.2022.996489. eCollection 2022.
9
The inhibitory effect of human umbilical cord mesenchymal stem cells expressing anti-HAAH scFv-sTRAIL fusion protein on glioma.表达抗HAAH单链抗体片段-可溶性肿瘤坏死因子相关凋亡诱导配体融合蛋白的人脐带间充质干细胞对胶质瘤的抑制作用
Front Bioeng Biotechnol. 2022 Nov 8;10:997799. doi: 10.3389/fbioe.2022.997799. eCollection 2022.
10
Discriminators of pseudoprogression and true progression in high-grade gliomas: A systematic review and meta-analysis.高级别胶质瘤中假性进展和真性进展的鉴别因素：系统评价和荟萃分析。
Sci Rep. 2022 Aug 2;12(1):13258. doi: 10.1038/s41598-022-16726-x.
本文引用的文献
1
Heat shock protein vaccines against glioblastoma: from bench to bedside.针对胶质母细胞瘤的热休克蛋白疫苗：从实验台到临床应用
J Neurooncol. 2015 Jul;123(3):441-8. doi: 10.1007/s11060-015-1837-7. Epub 2015 Jun 21.
2
Depression screening in patients with brain tumors: a review.脑肿瘤患者的抑郁筛查：综述
CNS Oncol. 2015;4(2):71-8. doi: 10.2217/cns.14.60.
3
Dendritic cell immunotherapy for solid tumors: evaluation of the DCVax® platform in the treatment of glioblastoma multiforme.实体瘤的树突状细胞免疫疗法：DCVax®平台在多形性胶质母细胞瘤治疗中的评估
CNS Oncol. 2015;4(2):63-9. doi: 10.2217/cns.14.54.
4
The effect of re-operation on survival in patients with recurrent glioblastoma.再次手术对复发性胶质母细胞瘤患者生存率的影响。
Anticancer Res. 2015 Mar;35(3):1743-8.
5
New developments in the pathogenesis and therapeutic targeting of the IDH1 mutation in glioma.胶质瘤 IDH1 突变发病机制和治疗靶点的新进展。
Int J Med Sci. 2015 Jan 20;12(3):201-13. doi: 10.7150/ijms.11047. eCollection 2015.
6
Rindopepimut: a promising immunotherapeutic for the treatment of glioblastoma multiforme.rindopepimut：一种用于治疗多形性胶质母细胞瘤的有前景的免疫疗法。
Immunotherapy. 2014;6(6):679-90. doi: 10.2217/imt.14.21.
7
A vaccine targeting mutant IDH1 induces antitumour immunity.针对突变 IDH1 的疫苗可诱导抗肿瘤免疫。
Nature. 2014 Aug 21;512(7514):324-7. doi: 10.1038/nature13387. Epub 2014 Jun 25.
8
Single-agent bevacizumab or lomustine versus a combination of bevacizumab plus lomustine in patients with recurrent glioblastoma (BELOB trial): a randomised controlled phase 2 trial.贝伐珠单抗单药或洛莫司汀单药与贝伐珠单抗联合洛莫司汀治疗复发性胶质母细胞瘤患者的比较（BELOB 试验）：一项随机对照 2 期试验。
Lancet Oncol. 2014 Aug;15(9):943-53. doi: 10.1016/S1470-2045(14)70314-6. Epub 2014 Jul 15.
9
Reoperation for recurrent high-grade glioma: a current perspective of the literature.复发性高级别胶质瘤的再次手术：文献综述
Neurosurgery. 2014 Nov;75(5):491-9; discussion 498-9. doi: 10.1227/NEU.0000000000000486.
10
Phase II trial of 7 days on/7 days off temozolmide for recurrent high-grade glioma.替莫唑胺7天用药/7天停药方案用于复发性高级别胶质瘤的II期试验
Neuro Oncol. 2014 Sep;16(9):1255-62. doi: 10.1093/neuonc/nou044. Epub 2014 Mar 26.
Zotero 插件